ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Valneva SE

Valneva SE (AYJ)

1,943
-0,018
(-0,92%)
Geschlossen 24 Dezember 10:00PM
Echtzeitdaten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
1,943
Gebot
1,934
Fragen
1,952
Volumen
108.734
1,889 Tagesbereich 2,03
1,724 52-Wochen-Bereich 4,984
Marktkapitalisierung
Handelsende
1,961
Handelsbeginn
2,00
Letzte Trade
100
@
1.933
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
92.644
Ausgegebene Aktien
138.202.132
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,60
Gewinn pro Aktie (EPS)
-0,73
Erlöse
175,73M
Nettogewinn
-101,43M

Über Valneva SE

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Saint-herblain, Loire-atlantique, Fra
Gegründet
-
Valneva SE is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker AYJ. The last closing price for Valneva was 1,96 €. Over the last year, Valneva shares have traded in a share price range of 1,724 € to 4,984 €.

Valneva currently has 138.202.132 shares in issue. The market capitalisation of Valneva is 271,01 € million. Valneva has a price to earnings ratio (PE ratio) of -2.60.

AYJ Neueste Nachrichten

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India Saint-Herblain (France), Pune, (India), December 19, 2024 – Valneva SE (“Valneva” or “the...

Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India

Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India Saint-Herblain (France), Pune, (Inde), le 19 décembre 2024 –...

VALNEVA - Declaration of shares and voting rights: November 30, 2024

VALNEVA - Declaration of shares and voting rights: November 30, 2024 VALNEVA Declaration of shares and voting rights November 30, 2024______________________________________________________________...

Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024

Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024 VALNEVA Déclaration d’actions et de droits de vote 30 novembre 2024________________________________________...

Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya

Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya Saint-Herblain (France), le 4 décembre 2024 – Valneva SE...

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal Saint-Herblain (France), December 4, 2024 – Valneva SE (Nasdaq:...

Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ®

Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ® Les niveaux d’anticorps demeurent élevés avec un...

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® Antibody levels remained high at 96% seroresponse in line with the two-year...

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA To potentially include adolescents and antibody persistence up to two years Saint Herblain...

Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ®

Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ® Avec pour objectif l’extension de l’utilisation aux adolescents et l’inclusion de la...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0935.027027027031.852.29999991.7241561131.9103855DE
4-0.105-5.1269531252.0482.29999991.7241391651.91059972DE
12-0.783-28.72340425532.7262.8261.724926442.18242232DE
26-1.245-39.05269761613.1884.0981.724791102.62237649DE
52-2.568-56.92751052984.5114.9841.724739563.11908732DE
156-23.837-92.463149728525.7826.941.724438857.22522012DE
260-1.152-37.22132471733.09529.61.7245249310.69174505DE

AYJ - Frequently Asked Questions (FAQ)

What is the current Valneva share price?
The current share price of Valneva is 1,943 €
How many Valneva shares are in issue?
Valneva has 138.202.132 shares in issue
What is the market cap of Valneva?
The market capitalisation of Valneva is EUR 271,01M
What is the 1 year trading range for Valneva share price?
Valneva has traded in the range of 1,724 € to 4,984 € during the past year
What is the PE ratio of Valneva?
The price to earnings ratio of Valneva is -2,6
What is the cash to sales ratio of Valneva?
The cash to sales ratio of Valneva is 1,5
What is the reporting currency for Valneva?
Valneva reports financial results in EUR
What is the latest annual turnover for Valneva?
The latest annual turnover of Valneva is EUR 175,73M
What is the latest annual profit for Valneva?
The latest annual profit of Valneva is EUR -101,43M
What is the registered address of Valneva?
The registered address for Valneva is 6 RUE ALAIN BOMBARD, CAMPUS BIO-OUEST, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800
What is the Valneva website address?
The website address for Valneva is www.valneva.com
Which industry sector does Valneva operate in?
Valneva operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
0RARAPT Therapeutics Inc
1,61 €
(101,25%)
83,81k
KASHIntellabridge Technology Corp
0,047 €
(88,00%)
1,24M
4APApollo Minerals Ltd
0,01 €
(66,67%)
30
AWY0Percheron Therapeutics Ltd
0,007 €
(55,56%)
660k
1W81WISeKey International Holding Ltd
9,70 €
(44,78%)
4,81k
WWTWater Ways Technologies Inc
0,0045 €
(-95,91%)
2,53k
L7C2Windfall Geotek Inc
0,0025 €
(-70,59%)
40k
QP9Atco Mining Inc
0,003 €
(-55,88%)
1,5k
0PV2Moovly Media Inc
0,002 €
(-55,56%)
500
8QPFidus Investment Corp
9,5899 €
(-51,32%)
220
D7GNel ASA
0,2496 €
(-0,79%)
3,89M
RQ0DWave Quantum Inc
7,896 €
(24,07%)
2,16M
FWR0Yumy Candy Company Inc the
0,0352 €
(40,80%)
2,12M
PF8European Lithium Limited
0,0204 €
(-0,97%)
2,07M
DI6Distribuidora Internacional De Alimentacion SA
0,017 €
(1,80%)
1,83M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock